Abattis Announces Zoning Approval on the Experion MMPR Application

Source:  Abattis Bioceuticals Corp., Press Release Oct 08 2014 VANCOUVER, B.C., Oct. 8, 2014 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX:ATTBF) (CSE:ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that through its wholly…

The post Abattis Announces Zoning Approval on the Experion MMPR Application appeared first on Marijuana Index.